In this online, self-learning activity:
Glaucoma, a heterogeneous disease leading to progressive damage to the optic nerve, causes irreversible vision loss and affects approximately 64 million people worldwide.The prevalence of glaucoma is increasing, and more than 100 million people will have glaucoma by 2040. Approximately half of all individuals with glaucoma are unaware of their condition due to the asymptomatic nature of the disease. Although the incidence of glaucoma-related blindness has decreased over the last 20 years, thanks to effective management strategies, 13% to 40% of people with glaucoma still develop unilateral or bilateral blindness, typically at a rate of 1.1% per year.
The following healthcare professionals: Ophthalmologists; physician assistants, nurse practitioners, nurses, and pharmacists with an interest in ophthalmology or diseases affecting the eye; and any other healthcare professionals with an interest in or who clinically encounter patients with glaucoma.
This program is supported by an educational grant from Bausch & Lomb.
Learners may participate in this activity free of charge.
Release Date: April 24, 2021 -- Expiration Date: April 24, 2023
Faculty: Robert Chang, MD
Monitoring intraocular pressure (IOP) and optimizing targets.
Current and emerging treatment options for glaucoma.
By the end of the session the participant will be able to:
ACCME Activity #201746223ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Faculty Disclosure: Robert Chang, MD, Assistant Professor of Ophthalmology at the Stanford University Medical Center, Stanford, CA, discloses that he has received financial compensation as a consultant for Aerie and Ivantis.
Disclosures of Educational Planners: Charles Turck, PharmD, BCPS, BCCCP, President of ScientiaCME, has no relevant conflicts of interest to disclose.
Commercial Support Disclosure: This program is supported by an educational grant from Bausch & Lomb.
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.